Lung Cancer News and Research

Latest Lung Cancer News and Research

RUFY1-RET fusion identified as mechanism of resistance to lorlatinib in lung cancer

A new case report was published in Volume 16 of Oncotarget on February 5, 2025, titled "Acquired RUFY1-RET rearrangement as a mechanism of resistance to lorlatinib in a patient with CD74-ROS1 rearranged non-small cell lung cancer: A case report."

6 Feb 2025

Microbes in your gut could determine cancer treatment outcomes

Researchers reveal that gut microbiota influence the effectiveness of immune checkpoint inhibitors (ICIs) in cancer treatment, with specific bacterial strains enhancing or inhibiting anti-tumor immunity.

4 Feb 2025

Researchers develop model to identify tumor-fighting immune cells in lung cancer patients

Researchers at the Johns Hopkins Kimmel Cancer Center and Bloomberg~Kimmel Institute for Cancer Immunotherapy have developed a computer model to help scientists identify tumor-fighting immune cells in patients with lung cancer treated with immune checkpoint inhibitors.

3 Feb 2025

Study could help predict treatment response for KRASG12C-mutant non-small cell lung cancer

A new study from Moffitt Cancer Center could help doctors predict how well patients with a specific type of lung cancer will respond to new therapies.

31 Jan 2025

New AI approach enhances personalized medicine in cancer care

Personalized medicine aims to tailor treatments to individual patients. Until now, this has been done using a small number of parameters to predict the course of a disease.

30 Jan 2025

Chemotherapy linked to persistent nerve pain in 4 in 10 cancer patients

Worldwide, cancer chemotherapy is linked to persistent severe peripheral nerve pain (neuropathy) for around 4 in every 10 patients treated with these drugs, suggests a pooled data analysis of the available evidence, published in the open access journal Regional Anesthesia & Pain Medicine.

29 Jan 2025

An Arm and a Leg: The ‘Shkreli Awards’ — for dysfunction and profiteering in health care

Every year, a health care think tank called the Lown Institute ranks the 10 worst examples of "profiteering and dysfunction" in health care and "honors" the winners.

27 Jan 2025

Ross procedure offers durable results in young patients

Young patients who have undergone the Ross procedure for aortic valve disease have shown excellent long-term survival, the majority without the need for additional surgery two decades later.

27 Jan 2025

Mechanical aortic valves showed improved long-term survival in patients aged 60 and younger

A late-breaking study presented today at the 2025 Society of Thoracic Surgeons (STS) Annual Meeting reveals that mechanical aortic valve replacements (AVRs) provide significant long-term survival benefits for patients aged 60 and younger compared to bioprosthetic valves. The study, leveraging data from the STS Adult Cardiac Surgery Database (ACSD), offers the most comprehensive analysis to date of prosthetic valve outcomes, encompassing over 100,000 patients.

26 Jan 2025

Real-world data reveals survival benefits of anatomic resections for early-stage lung cancer

New research presented at the 2025 Society of Thoracic Surgeons (STS) Annual Meeting reveals that anatomic lung resections, such as lobectomy and segmentectomy, are associated with improved long-term survival compared to wedge resection for patients with early-stage non-small cell lung cancer (NSCLC).

26 Jan 2025

Surgeon preferences may explain differences in CABG survival rates

In patients undergoing coronary artery bypass grafting (CABG), a novel analysis evaluating surgeon preference for multi- versus single-arterial grafting may help explain the differing results between prior retrospective analyses and randomized controlled trials regarding long-term survival.

25 Jan 2025

AstraZeneca receives positive NICE recommendations for lung cancer treatment

AstraZeneca announced that this week it has received two positive recommendations from the National Institute for Health and Care Excellence (NICE) for the treatment of lung cancer patients across England and Wales.

25 Jan 2025

New machine learning approach improves single-cell data analysis

Our bodies are made up of around 75 billion cells. But what function does each individual cell perform and how greatly do a healthy person’s cells differ from those of someone with a disease?

23 Jan 2025

New copper detection tool may lead to lung cancer treatment breakthrough

The Chang Lab at Princeton Chemistry continues in its mission to elucidate the role of metal nutrients in human biology: last year, iron; this year, copper.

22 Jan 2025

Study offers insight into how senescent cells survive after cancer treatment

After treating a tumor with chemotherapy and radiotherapy, cells known as senescent cells can appear.

22 Jan 2025

Study finds anti-correlation of KLRG1 and PD-1 expression in tumor fighting T cells

A new research paper was published in Oncotarget's Volume 16 on January 20, 2025, titled "Anti-correlation of KLRG1 and PD-1 expression in human tumor CD8 T cells."

21 Jan 2025

Owlstone Medical announces $27 million USD first close in series E financing round

Owlstone Medical (“Owlstone”), the global leader in Breath Biopsy® for applications in early disease detection and precision medicine, today announced a first closing of $27 million (circa £22 million) in its Series E financing round.

16 Jan 2025

PFAS in US water linked to increased cancer risk

A study links PFAS contamination in drinking water to increased cancer risks, highlighting significant impacts on digestive, endocrine, and respiratory systems.

16 Jan 2025

Ultrasensitive ctDNA detection improves risk prediction in early-stage lung cancer

Ultrasensitive ctDNA detection with NeXT Personal shows 81% sensitivity in early-stage lung adenocarcinoma, improving prognostic accuracy and therapy guidance.

15 Jan 2025

ORACLE test enhances prediction of lung cancer outcomes

A new test, developed by researchers from UCL Cancer Institute and the Francis Crick Institute, can better predict lung cancer survival at the point of diagnosis, which could inform treatment decisions and potentially reduce the risk of the cancer returning or spreading.

13 Jan 2025

Lung Cancer News and Research

Latest Lung Cancer News and Research

RUFY1-RET fusion identified as mechanism of resistance to lorlatinib in lung cancer

Microbes in your gut could determine cancer treatment outcomes

Researchers develop model to identify tumor-fighting immune cells in lung cancer patients

Study could help predict treatment response for KRASG12C-mutant non-small cell lung cancer

New AI approach enhances personalized medicine in cancer care

Chemotherapy linked to persistent nerve pain in 4 in 10 cancer patients

An Arm and a Leg: The ‘Shkreli Awards’ — for dysfunction and profiteering in health care

Ross procedure offers durable results in young patients

Mechanical aortic valves showed improved long-term survival in patients aged 60 and younger

Real-world data reveals survival benefits of anatomic resections for early-stage lung cancer

Surgeon preferences may explain differences in CABG survival rates

AstraZeneca receives positive NICE recommendations for lung cancer treatment

New machine learning approach improves single-cell data analysis

New copper detection tool may lead to lung cancer treatment breakthrough

Study offers insight into how senescent cells survive after cancer treatment

Study finds anti-correlation of KLRG1 and PD-1 expression in tumor fighting T cells

Owlstone Medical announces $27 million USD first close in series E financing round

PFAS in US water linked to increased cancer risk

Ultrasensitive ctDNA detection improves risk prediction in early-stage lung cancer

ORACLE test enhances prediction of lung cancer outcomes

The ultimate guide to lung research tools and protocols eBook

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Lung Cancer News and Research

Latest Lung Cancer News and Research

The ultimate guide to lung research tools and protocols eBook

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Newsletters you may be interested in